Rao, Tanvi <br/><br/>
Association of Formulary Exclusions and Restrictions for Opioid Alternatives With Opioid Prescribing Among Medicare Beneficiaries.  [electronic resource] 

 -  JAMA network open  03 2020 
 - e200274 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2574-3805 
<br/><br/><label>Standard No.: </label>10.1001/jamanetworkopen.2020.0274  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Analgesics, Non-Narcotic--therapeutic use<br/>Analgesics, Opioid--therapeutic use<br/>Anti-Inflammatory Agents, Non-Steroidal--therapeutic use<br/>Anticonvulsants--therapeutic use<br/>Antidepressive Agents, Tricyclic--therapeutic use<br/>Formularies as Topic<br/>Humans<br/>Insurance Coverage--statistics & numerical data<br/>Medicare Part D--statistics & numerical data<br/>Muscle Relaxants, Central--therapeutic use<br/>Pain--drug therapy<br/>Practice Patterns, Physicians'--statistics & numerical data<br/>Prior Authorization<br/>Serotonin and Noradrenaline Reuptake Inhibitors--therapeutic use<br/>United States